Skip to main content

Advertisement

Log in

Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Invasive ductal carcinoma with lobular features (IDC-L) is not recognized as a distinct subtype of breast cancer, and its clinicopathologic features and outcomes are unknown. In this retrospective study, we focused on characterization of clinicopathologic features and outcomes of IDC-L and compared them to invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC). 183 cases of IDC-L from 1996 to 2011 were compared with 1,499 cases of IDC and 375 cases of ILC. Available slides of IDC-L (n = 150) were reviewed to quantify the lobular component (≤20, 21–50, 51–80, >80 %), defined as small cells individually dispersed, arranged in linear cords, or in loose aggregates without the formation of tubules or cohesive nests. E-cadherin immunostain was performed to confirm ductal origin. Compared to IDC, IDC-L was more likely to have lower histologic grade (p < 0.001), be positive for estrogen receptor (96 vs. 70 %; p < 0.0001) and progesterone receptor (84 vs. 57 %; p < 0.0001), and less likely to overexpress HER-2/neu (12 vs. 23 %; p = 0.001). Despite these favorable prognostic features, IDC-L had a higher frequency of nodal metastases (51 vs. 34 %; p < 0.0001) and a worse 5-year disease-free survival than IDC (hazard ratio = 0.454; p = 0.0004). ILC and IDC-L had similar clinicopathologic features and outcomes. The proportion of the lobular component in IDC-L had no impact on the size, nodal status, stage, or outcome. Our data suggest that although IDC-L may be a variant of IDC, with >90 % of cases being E-cadherin positive, the clinical and biological characteristics are more similar to that of ILC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sastre-Garau X, Jouve M, Asselain B et al (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 75(1):113–120

    Article  Google Scholar 

  2. Lamovec J, Bracko M (1991) Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 48(1):28–33

    Article  PubMed  CAS  Google Scholar 

  3. Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6(3):R149–R156

    Article  PubMed  Google Scholar 

  4. Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114(4):637–642

    PubMed  CAS  Google Scholar 

  5. Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9):1046–1052

    Article  PubMed  CAS  Google Scholar 

  6. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW (1982) Infiltrating lobular carcinoma of the breast. Histopathology 6(2):149–161

    Article  PubMed  CAS  Google Scholar 

  7. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20(6):479–489

    Article  PubMed  CAS  Google Scholar 

  8. Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421–1424

    Article  PubMed  Google Scholar 

  9. Reeves GK, Beral V, Green J, Gathani T, Bull D (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7(11):910–918

    Article  PubMed  CAS  Google Scholar 

  10. Lesser ML, Rosen PP, Kinne DW (1982) Multicentricity and bilaterality in invasive breast carcinoma. Surgery 91(2):234–240

    PubMed  CAS  Google Scholar 

  11. Nesland JM, Holm R, Johannessen JV (1985) Ultrastructural and immunohistochemical features of lobular carcinoma of the breast. J Pathol 145(1):39–52

    Article  PubMed  CAS  Google Scholar 

  12. Mendelson EB, Harris KM, Doshi N, Tobon H (1989) Infiltrating lobular carcinoma: mammographic patterns with pathologic correlation. AJR Am J Roentgenol 153(2):265–271

    Article  PubMed  CAS  Google Scholar 

  13. Kumar ND, Hart WR (1982) Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 50(10):2163–2169

    Article  PubMed  CAS  Google Scholar 

  14. Silverstein MJ, Lewinsky BS, Waisman JR et al (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73(6):1673–1677

    Article  PubMed  CAS  Google Scholar 

  15. Li CI, Moe RE, Daling JR (2003) Risk of mortality by histologic type of breast cancer among women aged 50–79 years. Arch Intern Med 163(18):2149–2153

    Article  PubMed  Google Scholar 

  16. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115(1):85–98

    Article  PubMed  CAS  Google Scholar 

  17. Wasif N, Maggard MA, Ko CY, Giuliano AE (2010) Invasive lobular versus ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 17(7):1862–1869

    Article  PubMed  Google Scholar 

  18. Korhonen T, Huhtala H, Holli K (2004) A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 85(1):23–29

    Article  PubMed  CAS  Google Scholar 

  19. Lee JH, Park S, Park HS, Park BW (2010) Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study. World J Surg Oncol 8:34

    Article  PubMed  CAS  Google Scholar 

  20. Li CI, Daling JR, Malone KE et al (2006) Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):946–954

    Article  PubMed  Google Scholar 

  21. Suryadevara A, Paruchuri LP, Banisaeed N, Dunington G, Rao KA (2010) The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis. World J Surg Oncol 8:51

    Article  PubMed  Google Scholar 

  22. Rakha EA, Gill MS, El-Sayed ME et al (2009) The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology. Breast Cancer Res Treat 114(2):43–50

    Article  Google Scholar 

  23. Af Bharat, Gao F, Margenthaler JA (2009) Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. Am J Surg 198(4):516–519

    Article  Google Scholar 

  24. Nassar H, Wallis T, Andea A, Dey J, Adsay V, Vischer D (2001) Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 14(9):836–841

    Article  PubMed  CAS  Google Scholar 

  25. Sabel MS, Jorns JM, Wu A, Myers J, Newman LA, Breslin TM (2012) Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am J Surg 204(1):66–77

    Article  PubMed  Google Scholar 

  26. Moore MM, Borossa G, Imbrie JZ et al (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231(6):877–882

    Article  PubMed  CAS  Google Scholar 

  27. Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26(18):3006–3014

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the UMHS Cancer Center Research Histology & Immunoperoxidase Lab for performing the E-cadherin immunostains and Steven C. Smith, M.D., Ph.D. for his assistance in the preparation of Fig. 2.

Conflict of interest

The authors have no disclosures or conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judy C. Pang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arps, D.P., Healy, P., Zhao, L. et al. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast. Breast Cancer Res Treat 138, 719–726 (2013). https://doi.org/10.1007/s10549-013-2493-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2493-2

Keywords

Navigation